66 related articles for article (PubMed ID: 12499253)
21. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
[TBL] [Abstract][Full Text] [Related]
22. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease.
Walling DM; Andritsos LA; Etienne W; Payne DA; Aronson JF; Flaitz CM; Nichols CM
J Med Virol; 2004 Sep; 74(1):94-101. PubMed ID: 15258974
[TBL] [Abstract][Full Text] [Related]
23. Phylogenetic analysis of Portuguese Feline Immunodeficiency Virus sequences reveals high genetic diversity.
Duarte A; Tavares L
Vet Microbiol; 2006 Apr; 114(1-2):25-33. PubMed ID: 16384661
[TBL] [Abstract][Full Text] [Related]
24. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family.
Katoh M; Katoh M
Int J Mol Med; 2003 Jun; 11(6):683-9. PubMed ID: 12736707
[TBL] [Abstract][Full Text] [Related]
25. Feline immunodeficiency virus Orf-A localizes to the nucleus and induces cell cycle arrest.
Gemeniano MC; Sawai ET; Sparger EE
Virology; 2004 Aug; 325(2):167-74. PubMed ID: 15246256
[TBL] [Abstract][Full Text] [Related]
26. Integration site choice of a feline immunodeficiency virus vector.
Kang Y; Moressi CJ; Scheetz TE; Xie L; Tran DT; Casavant TL; Ak P; Benham CJ; Davidson BL; McCray PB
J Virol; 2006 Sep; 80(17):8820-3. PubMed ID: 16912328
[TBL] [Abstract][Full Text] [Related]
27. Lentivirus envelope protein exerts differential neuropathogenic effects depending on the site of expression and target cell.
Noorbakhsh F; Tang Q; Liu S; Silva C; van Marle G; Power C
Virology; 2006 May; 348(2):260-76. PubMed ID: 16492386
[TBL] [Abstract][Full Text] [Related]
28. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.
Paillot R; Richard S; Bloas F; Piras F; Poulet H; Brunet S; Andreoni C; Juillard V
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):1-14. PubMed ID: 15910988
[TBL] [Abstract][Full Text] [Related]
29. Glycan moiety modifications of feline alpha1-acid glycoprotein in retrovirus (FIV, FeLV) affected cats.
Pocacqua V; Provasi E; Paltrinieri S; Gelain E; Comunian C; Ceciliani F
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):17-26. PubMed ID: 15982476
[TBL] [Abstract][Full Text] [Related]
30. Comparative replication kinetics of two cytopathic feline lentiviruses ex vivo.
Sutton CA; Gordnier PM; Avery RJ; Casey JW
Virology; 2005 Feb; 332(2):519-28. PubMed ID: 15680417
[TBL] [Abstract][Full Text] [Related]
31. New genes involved in cancer identified by retroviral tagging.
Suzuki T; Shen H; Akagi K; Morse HC; Malley JD; Naiman DQ; Jenkins NA; Copeland NG
Nat Genet; 2002 Sep; 32(1):166-74. PubMed ID: 12185365
[TBL] [Abstract][Full Text] [Related]
32. Molecular and immunophenotypical characterization of a feline immunodeficiency virus (FIV)-associated lymphoma: a direct role for FIV in B-lymphocyte transformation?
Beatty JA; Callanan JJ; Terry A; Jarrett O; Neil JC
J Virol; 1998 Jan; 72(1):767-71. PubMed ID: 9420284
[TBL] [Abstract][Full Text] [Related]
33. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
[TBL] [Abstract][Full Text] [Related]
34. Evolution of the long terminal repeat and accessory genes of feline immunodeficiency virus genomes from naturally infected cougars.
Poss M; Ross H
Virology; 2008 Jan; 370(1):55-62. PubMed ID: 17904608
[TBL] [Abstract][Full Text] [Related]
35. Recombination in feline immunodeficiency virus genomes from naturally infected cougars.
Bruen TC; Poss M
Virology; 2007 Aug; 364(2):362-70. PubMed ID: 17445856
[TBL] [Abstract][Full Text] [Related]
36. Recombination in feline lentiviral genomes during experimental cross-species infection.
Poss M; Idoine A; Ross HA; Terwee JA; VandeWoude S; Rodrigo A
Virology; 2007 Mar; 359(1):146-51. PubMed ID: 17046045
[TBL] [Abstract][Full Text] [Related]
37. Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats.
Pistello M; Matteucci D; Giannecchini S; Bonci F; Sichi O; Presciuttini S; Bendinelli M
Clin Diagn Lab Immunol; 2003 Nov; 10(6):1109-16. PubMed ID: 14607875
[TBL] [Abstract][Full Text] [Related]
38. Molecular biology of the feline immunodeficiency virus auxiliary genes.
Tomonaga K; Mikami T
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1611-21. PubMed ID: 8760407
[No Abstract] [Full Text] [Related]
39. Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections.
Elder JH; Phillips TR
Adv Virus Res; 1995; 45():225-47. PubMed ID: 7793326
[No Abstract] [Full Text] [Related]
40. Japan okays test-tube baby gene tests.
Saegusa A
Nature; 1998 Jul; 394(6689):110. PubMed ID: 9671288
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
